Chemcon Speciality Chemicals Limited (NSE:CHEMCON)
India · Delayed Price · Currency is INR 171.00
-4.83 (-2.75%)
Feb 19, 2026, 3:30 PM IST
NSE:CHEMCON Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 2,194 | 2,074 | 2,671 | 3,029 | 2,571 | 2,435 |
Other Revenue | 0.19 | 0.19 | - | - | - | - |
| 2,195 | 2,074 | 2,671 | 3,029 | 2,571 | 2,435 | |
Revenue Growth (YoY) | 3.47% | -22.34% | -11.82% | 17.80% | 5.59% | -7.08% |
Cost of Revenue | 1,401 | 1,232 | 1,912 | 1,779 | 1,263 | 1,237 |
Gross Profit | 793.16 | 842.59 | 758.95 | 1,250 | 1,308 | 1,197 |
Selling, General & Admin | 202.11 | 198.56 | 185.16 | 209.31 | 194.46 | 161.93 |
Other Operating Expenses | 317.61 | 314.25 | 299.92 | 333.03 | 290.62 | 217.75 |
Operating Expenses | 630.17 | 617.92 | 588.17 | 626.05 | 547.78 | 440.45 |
Operating Income | 163 | 224.67 | 170.78 | 623.6 | 760.58 | 756.98 |
Interest Expense | -18.93 | -34.49 | -34.55 | -14.34 | -5.4 | -35.38 |
Interest & Investment Income | 133.53 | 133.53 | 122.28 | 94.37 | 81.47 | 32.57 |
Currency Exchange Gain (Loss) | 8.49 | 8.49 | 4.21 | 32.06 | 10.76 | 4.03 |
Other Non Operating Income (Expenses) | -0.15 | -0.44 | -0.42 | -0.36 | -0.29 | 8.8 |
EBT Excluding Unusual Items | 285.93 | 331.75 | 262.31 | 735.32 | 847.12 | 767 |
Gain (Loss) on Sale of Investments | 0.73 | 0.73 | - | - | - | - |
Gain (Loss) on Sale of Assets | -0.41 | -0.41 | 0.27 | 6.53 | -3.09 | -0.51 |
Asset Writedown | -0.61 | -0.61 | - | -0.34 | -4.08 | -0.36 |
Other Unusual Items | - | - | - | - | - | -5.57 |
Pretax Income | 285.64 | 331.46 | 262.58 | 741.51 | 839.96 | 760.56 |
Income Tax Expense | 73.91 | 86.94 | 70.65 | 190.41 | 212.39 | 196.58 |
Net Income | 211.73 | 244.52 | 191.93 | 551.1 | 627.57 | 563.98 |
Net Income to Common | 211.73 | 244.52 | 191.93 | 551.1 | 627.57 | 563.98 |
Net Income Growth | -9.55% | 27.40% | -65.17% | -12.18% | 11.27% | 15.45% |
Shares Outstanding (Basic) | 37 | 37 | 37 | 37 | 37 | 34 |
Shares Outstanding (Diluted) | 37 | 37 | 37 | 37 | 37 | 34 |
Shares Change (YoY) | 0.05% | - | - | -0.00% | 7.03% | 7.70% |
EPS (Basic) | 5.78 | 6.68 | 5.24 | 15.04 | 17.13 | 16.48 |
EPS (Diluted) | 5.78 | 6.68 | 5.24 | 15.04 | 17.13 | 16.48 |
EPS Growth | -9.60% | 27.40% | -65.16% | -12.20% | 3.95% | 7.22% |
Free Cash Flow | - | 309.45 | -308.77 | -334.54 | 240.41 | 331.71 |
Free Cash Flow Per Share | - | 8.45 | -8.43 | -9.13 | 6.56 | 9.69 |
Dividend Per Share | - | - | - | 4.000 | - | - |
Gross Margin | 36.14% | 40.62% | 28.42% | 41.26% | 50.89% | 49.18% |
Operating Margin | 7.43% | 10.83% | 6.39% | 20.59% | 29.58% | 31.09% |
Profit Margin | 9.65% | 11.79% | 7.19% | 18.20% | 24.41% | 23.16% |
Free Cash Flow Margin | - | 14.92% | -11.56% | -11.04% | 9.35% | 13.62% |
EBITDA | 269.85 | 329.72 | 273.44 | 704.77 | 819.65 | 811.94 |
EBITDA Margin | 12.30% | 15.90% | 10.24% | 23.27% | 31.88% | 33.35% |
D&A For EBITDA | 106.86 | 105.06 | 102.66 | 81.17 | 59.07 | 54.96 |
EBIT | 163 | 224.67 | 170.78 | 623.6 | 760.58 | 756.98 |
EBIT Margin | 7.43% | 10.83% | 6.39% | 20.59% | 29.58% | 31.09% |
Effective Tax Rate | 25.87% | 26.23% | 26.91% | 25.68% | 25.29% | 25.85% |
Revenue as Reported | 2,338 | 2,217 | 2,803 | 3,162 | 2,663 | 2,481 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.